Benzothiazolyl derivatives

Details Benzothiazolyl derivatives Benzothiazolyl derivatives

2007-11-20

2007-11-20

Pryor, Alton (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S163000

Reexamination Certificate

active

10871952

ABSTRACT:
The present invention relates to compounds of formula (I)wherein R1, R2, R3R3aand R3bare as provided in the description, and pharmaceutically acceptable salts thereof, for use in the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors such as obesity.

REFERENCES:
patent: 3940418 (1976-02-01), Hamilton
patent: 5462960 (1995-10-01), Barth et al.
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 6433188 (2002-08-01), Corbett et al.
patent: 6441184 (2002-08-01), Corbett et al.
patent: 6448399 (2002-09-01), Corbett et al.
patent: 6545155 (2003-04-01), Corbett et al.
patent: 576357 (1993-06-01), None
patent: 0 604 657 (1994-07-01), None
patent: 656 354 (1994-11-01), None
patent: 656 354 (1994-11-01), None
patent: 658 546 (1994-12-01), None
patent: 658 546 (1994-12-01), None
patent: WO96/02248 (1996-02-01), None
patent: WO97/19063 (1997-05-01), None
patent: WO 00/15609 (2000-03-01), None
patent: WO 00/46209 (2000-08-01), None
patent: WO 01/32663 (2001-05-01), None
patent: WO 01/64632 (2001-09-01), None
patent: WO 01/64633 (2001-09-01), None
patent: WO 01/64634 (2001-09-01), None
patent: WO 01/70700 (2001-09-01), None
patent: WO 02/28346 (2002-04-01), None
patent: WO 03/045386 (2003-06-01), None
Kurzer et al., Heterocyclic compounds from urea derivatives, (J. Chem. Soc., Abs. (1962), 230-6—XP-002296385).
F. Barth, et al., “Cannabinoid antagonists: From research tools to potential new drugs.” Abstracts of Papers, 222ndASC National Meeting, Chicago, IL Aug. 26-30, 2001.
F.M. Casiano, et. al., NIDA Res. Monogr. 105 (1991) 295-6.
G. Colombo, et. al., Life Sci. 63 (8) (1998) L-113-PL117.
W.A. Devane, et. al., Science 258 (1992) 1946-9.
V. Di Marzo, et. al., Nature 410 (6830) 822-825.
V. Di Marzo, et. al, Trends in Neuroscience 21 (12) (1998) 521-8.
C. Felder, et. al., J. Pharmacol. Exp. Ther. 284 (1) (1998) 291-7.
C. Felder, et. al., Proc. Natl. Acad. Sci. USA 90 (16) (1993) 7656-60.
Y. Gaoni, et. al., J. Am. Chem. Soc., 86 (1964) 1646.
K. Hosohata, et. al., Life Sci. 61 (1997) 115-118.
M. Kanyonyo, et. al., Bioorg. Med. Chem. Lett. 9 (15) (1999) 2233-2236.
R. Mechoulam (Ed.) in “Cannabinoids as therapeutic Agents”, (1986) p. 1-20, CRC Press.
S. Munro, et. al., Nature 365 (1993) 61-61.
F. Ooms, et. al., J. Med. Chem 45 (9) (2002) 1748-1756.
M. Pacheco, et. al., J. Pharmacol. Exp. Ther. 257 (1) (1991) 170-183.
R.G. Pertwee, Curr. Med. Chem., 6 (8) (1999) 635-664.
R.G. Pertwee, Life Sci. 56 (23-24) (1995) 1949-55.
R.G. Pertwee, Pharmaceut. Sci. 3 (11) (1997) 539-545.
C. Porter, et. al., Pharmacol. Ther., 90 (1) (2001) 45-60.
D. Shire, J. Biol. Chem. 270 (8) (1995) 3726-31.
C.M. Williams, et. al., Psychopharmacology 143 (3) (1999) 315-317.
E.M. Williamson, et. al., Drugs 60 (6) (2000) 1303-1314.
Kurzer, Frederick et al, Journal of the Chemical Society, Abstracts 230-6 Coden: JCSAAZ; ISSN: 0590-9791 (1962).
Pertwee R.G., Pharmacolog and Therapeutics, XP002226467 vol. 74, No. 2, pp. 129-180 (1997).

Affiliated with

Also associated with

Rating

Benzothiazolyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzothiazolyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazolyl derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3819653